Healthcare Utilization and Costs associated with Hereditary Hemorrhagic Telangiectasia Patients in a Large US Claims Database

OBJECTIVE: To assess the health care costs and utilization in patients with hereditary hemorrhagic telangiectasia (HHT) in the United States. PATIENTS AND METHODS: Retrospective analysis of patients with HHT diagnosed between 2007 and 2017 was performed using deidentified administrative claims data...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Mayo Clin Proc Innov Qual Outcomes
Asıl Yazarlar: Hasan Albitar, Hasan Ahmad, Van Houten, Holly, Sangaralingham, Lindsey R., Knoedler, Meghan, Almodallal, Yahya, Alkurashi, Adham K., De Moraes, Alice Gallo, Cajigas, Hector, DuBrock, Hillary, Warad, Deepti, Demirel, Nadir, Krowka, Michael, Brinjikji, Waleed, Iyer, Vivek N.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elsevier 2020
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7930864/
https://ncbi.nlm.nih.gov/pubmed/33718784
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mayocpiqo.2020.08.010
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller